Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.3650
-0.0250 (-6.41%)
Oct 28, 2025, 4:10 PM AEST
Imugene Market Cap
Imugene has a market cap or net worth of 115.37 million as of October 28, 2025. Its market cap has decreased by -68.34% in one year.
Market Cap
115.37M
Enterprise Value
104.09M
Revenue
4.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
Market Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 115.37M, an increase of 1,463.60%. That is a compound annual growth rate of 12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 115.37M | -58.07% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | 474.09M | 234.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.70B |
| Pro Medicus | 29.45B |
| Cochlear | 18.98B |
| Sonic Healthcare | 10.75B |
| Ramsay Health Care | 7.34B |
| Telix Pharmaceuticals | 5.59B |
| Ansell | 4.84B |
| Mesoblast | 3.30B |